Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75e20dbf6ef294e750e09e2d26dded8d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-31544 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-236 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-252 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0029 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0011 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82 |
filingDate |
2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15348e1fd8d7923550213aff5db5834 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e24d2f914e7b5d9356485ab81c0db45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f35bf1f015c2fd75f1851844b15d156f |
publicationDate |
2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2016193202-A |
titleOfInvention |
Immobilized bioactive substance with great bioactivity after physical manipulation or sterilization |
abstract |
Disclosed is a medical device having a biologically active substance immobilized on a surface, which can be sterilized and / or physically compressed and expanded and / or stored without significantly reducing biological activity. An oligosaccharide or polysaccharide having a substrate material; a polymer coating material bound to at least a portion of the surface of the substrate, and having an antithrombin III binding activity and covalently bound to at least a portion of the polymer coating material A biocompatible organic composition that is a polysaccharide non-covalently bonded to the polymer coating material, wherein the polysaccharide is selected from heparin, dextran sulfate, or dextran A medical device wherein the anti-thrombin III binding activity of the bioactive substance is at least 5 pmol antithrombin III (pimol / cm 2) per square centimeter of substrate material after sterilization of the substrate material or after compression and expansion. [Selection figure] None |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7365371-B2 |
priorityDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |